Dr. Lee is an epidemiologist at the forefront of integrating advanced methodologies with cutting-edge technologies. Her research is centered on unraveling the complex interplay between host factors, viral infections, and environmental influences that contribute to shaping cancer risk. Dr. Lee's impactful research has played a pivotal role in identifying critical risk factors and biomarkers, shedding light not only on cancer development but also aiding in the identification of high-risk individuals. Pioneering efforts from Dr. Lee’s team extend to the development of predictive models for various cancers, leveraging these insightful biomarkers. A substantial focus of her research is dedicated to assessing risk factors associated with liver cancer, biliary tract cancers, and other malignancies. Dr. Lee's lab excels in extensive database analysis, including national registries, enabling in-depth exploration into the potential impact of specific drug usage on cancer development.